Slowing COVID-19 Sales Will Drag On Roche In 2022

Growth To Be Flat Or Low Single Digit

 
• By Andrew McConaghie
  
Roche_Logo_Glass
2022 is also a big year for read-outs, including its Alzheimer's candidate gantenrumab. • Source: Alamy
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Earnings

More from Business